Pericardial Effusion Predicts Clinical Outcomes in Patients with COVID-19: A Nationwide Multicenter Study

Abstract

Rationale and objectivesThe prognostic role of pericardial effusion (PE) in Covid 19 is unclear. The aim of the present study was to estimate the prognostic role of pericardial effusion in patients with Covid 19 in a large multicentre setting. Materials and methodsThis retrospective study is a part of the German multicenter project RACOON (Radiological Cooperative Network of the Covid 19 pandemic). The acquired sample comprises 1197 patients, 363 (30.3%) women and 834 (69.7%) men. In every case, chest computed tomography was analyzed for PE. Data about 30-day mortality, need for mechanical ventilation and need for intensive care unit admission were collected. Data were evaluated by means of descriptive statistics. Group differences were calculated with Mann-Whitney test and Fisher exact test. Uni-and multivariable regression analyses were performed. ResultsOverall, 46.4% of the patients were admitted to intensive care unit (ICU), mechanical lung ventilation was performed in 26.6%, and 30-day mortality was 24%.PE was identified in 159 patients (13.3%). The presence of PE was associated with 30-day mortality: HR = 1.54, CI95% (1.05; 2.23), p=0.02 (univariable analysis), and HR = 1.60, CI95% (1.03; 2.48), p=0.03 (multivariable analysis). Furthermore, density of PE was associated with the need for intubation (OR = 1.02, CI95% (1.003; 1.05), p=0.03) and the need for ICU admission (OR = 1.03, CI95% (1.005; 1.05), p=0.01) in univariable regression analysis. The presence of PE was associated with 30-day mortality in male patients, HR=1.56, CI95%(1.01-2.43), p=0.04 (multivariable analysis). In female patients, none of PE values predicted clinical outcomes. ConclusionThe prevalence of PE in Covid 19 is 13.3%. PE is an independent predictor of 30-day mortality in male patients with Covid 19. In female patients, PE plays no predictive role.